Collaborating on Rare Disease R&D

Collaborating on Rare Disease R&D

This week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn of Corbus Pharmaceuticals’ collaboration with University of Pennsylvania on a Phase 2 study, which has shown positive results. Read more >>

Share this post